| Authors: |
O'Brien SA; Department of Inflammation and Oncology, Amgen Research, Amgen Inc., South San Francisco, CA, 94080, USA., Orf J; Department of Inflammation and Oncology, Amgen Research, Amgen Inc., South San Francisco, CA, 94080, USA., Skrzypczynska KM; Department of Inflammation and Oncology, Amgen Research, Amgen Inc., South San Francisco, CA, 94080, USA., Tan H; Department of Inflammation and Oncology, Amgen Research, Amgen Inc., South San Francisco, CA, 94080, USA., Kim J; Department of Inflammation and Oncology, Amgen Research, Amgen Inc., South San Francisco, CA, 94080, USA., DeVoss J; Department of Inflammation and Oncology, Amgen Research, Amgen Inc., South San Francisco, CA, 94080, USA., Belmontes B; Department of Inflammation and Oncology, Amgen Research, Amgen Inc., South San Francisco, CA, 94080, USA., Egen JG; Department of Inflammation and Oncology, Amgen Research, Amgen Inc., South San Francisco, CA, 94080, USA. jegen@amgen.com. |